Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme (Q36859619)
Jump to navigation
Jump to search
scientific article published on 22 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme |
scientific article published on 22 April 2015 |
Statements
1 reference
Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme (English)
1 reference
Jeffrey R Curtis
1 reference
Eun Bong Lee
1 reference
Irina V Kaplan
1 reference
Kenneth Kwok
1 reference
Jamie Geier
1 reference
Birgitta Benda
1 reference
Koshika Soma
1 reference
Lisy Wang
1 reference
Richard Riese
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference